Poly（phenylene ethynylene）s （P1） with 4-vinylaniline pendant groups were successfully prepared by the Sonogashira coupling polymerization bevween 1,4-diethynyl-2,5-bis（pentyloxy）benzene and 4-[2-（2,5-dibromophenyl）vinyl]- aniline. In comparison with its analogue P2 without amino group, the emission of F＇I is only enihanced by aggregation when adding n-hexane into its THF solution, exhibiting an aggregation-induced emission enhancement （AIEE） effect. When methanol or water instead of hexane was added into THF solution, P1, however, didn＇t show AII：~E. The results indicated that amino groups strengthen the inter-chain and intra-chain interactions in P1 and restrict the no^-radiative energy transition. This strategy can provide a platform for developing highly sensitive and efficient bio- and chemosensors.
Polyelectrolyte PTPEPyH, containing tetraphenylethene (TPE) and pyridinium, was synthesized. Its optical properties were investigated with spectroscopies and the results showed that there were two emission-enhanced stages in the interaction between positive-charged PTPEPyH and negative-charged biomacromolecule heparin. The mechanism was very different due to the reduced non-radiative energy loss and the change of surroundings. The polyelectrolyte PTPEPyH, compared with ChS and HA, also showed high selectivity for heparin in the buffer solution and could be used as a potential bio-probe for heparin quantification in the clinical full range.
Polyelectrolyte PTPEPyH,containing tetraphenylethene(TPE)and pyridinium,was synthesized.Its optical properties were investigated with spectroscopies and the results showed that there were two emission-enhanced stages in the interaction between positive-charged PTPEPyH and negative-charged biomacromolecule heparin.The mechanism was very different due to the reduced non-radiative energy loss and the change of surroundings.The polyelectrolyte PTPEPyH,compared with ChS and HA,also showed high selectivity for heparin in the buffer solution and could be used as a potential bio-probe for heparin quantification in the clinical full range.
